In accordance with the U.S Food and Drug Administration (FDA) final rule regarding Laboratory Developed Tests (LDTs), the North Carolina State Laboratory of Public Health is implementing this medical device form to collect information regarding medical device performance and adverse events. As defined, a medical device is an in vitro diagnostic product, in this case an LDT, used, designed, or manufactured in a single, certified CLIA laboratory for clinical use. An adverse event is a serious injury or illness that is life threatening, results in permanent impairment or damage to a body function or structure or requires medical intervention to prevent the permanent impairment or damage to a body function or structure.
If your facility submits specimens to the North Carolina State Laboratory of Public Health (NCSLPH) for any of the tests below, and have encountered a problem with
please use the Medical Device Reporting form to report the issue, immediately upon discovery.
NCSLPH LDT list:
4-hydroxy-3-nitrophenylacetic acid (HNPAA) |
Measles RT-PCR |
Abrine/Ricinine |
Mercury in Urine |
Antimicrobial Susceptibility Testing for Mycobacterium tuberculosis complex |
Mycobacterium tuberculosis complex/Mycobacterium avium-intracellulare complex (TBMAC) PCR |
Blood Lead by ICP-MS |
Organophosphate nerve agents (OPNA) Serum |
Blood Metals |
Organophosphate nerve agents (OPNA) Urine |
Bordetella pertussis PCR |
Orthopoxvirus RT-PCR |
Brucella RT-PCR |
Severe Combined Immunodeficiency (SCID)/ Spinal Muscular Atrophy (SMA) |
Burkholderia RT-PCR |
Tetramine |
Carbapenem Resistant Enterobacterales (CRE) mCIM (Clinical and Surveillance) |
Tuberculosis B Resistance surveillance/retrospective |
Carbapenem Resistant Enterobacterales (CRE) real-time PCR (Clinical and Surveillance) |
Urine Metals |
Chikungunya IgM ELISA |
Varicella-Zoster Virus (VZV) RT-PCR |
Coxiella and DNA Blood mini kit extraction |
Volatile Organic Compounds |
Cyanide |
Whole Genome Sequencing (WGS) for Listeria Monocytogenes (Surveillance only) |
Cystic Fibrosis Transmembrane Conductance Regular (CFTR) DNA |
Whole Genome Sequencing (WGS) for Salmonella serotyping (Clinical and Surveillance) |
Francisella tularensis DFA |
Whole Genome Sequencing (WGS) for Shigella (Surveillance only) |
Francisella tularensis RT-PCR |
Whole Genome Sequencing (WGS) for STEC (Surveillance only) |
Galactosemia amplification refractory mutation system polymerase chain reaction (GALT ARMS) PCR |
Whole Genome Sequencing for Campylobacter (Surveillance only) |
HMAS for Salmonella (CDC pilot study) |
X-linked Adrenoleukodystrophy (ALD)- R (Relex Testing) (ALD-R) |
Known Phenylketonuria (PKU) |
Yersinia pestis RT-PCR |
LaCrosse IgM ELISA |
|
Once submission is complete, the laboratory will contact you for further information if necessary.